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Abstract
Background: The transcription factor AP-1 positively controls synaptic plasticity at the Drosophila
neuromuscular junction. Although in motor neurons, JNK has been shown to activate AP-1, a
positive regulator of growth and strength at the larval NMJ, the consequences of JNK activation
are poorly studied. In addition, the downstream transcriptional targets of JNK and AP-1 signaling
in the Drosophila nervous system have yet to be identified. Here, we further investigated the role
of JNK signaling at this model synapse employing an activated form of JNK-kinase; and using Serial
Analysis of Gene Expression and oligonucleotide microarrays, searched for candidate early targets
of JNK or AP-1 dependent transcription in neurons.
Results: Temporally-controlled JNK induction in postembryonic motor neurons triggers synaptic
growth at the NMJ indicating a role in developmental plasticity rather than synaptogenesis. An
unexpected observation that JNK activation also causes a reduction in transmitter release is
inconsistent with JNK functioning solely through AP-1 and suggests an additional, yet-unidentified
pathway for JNK signaling in motor neurons. SAGE profiling of mRNA expression helps define the
neural transcriptome in Drosophila. Though many putative AP-1 and JNK target genes arose from
the genomic screens, few were confirmed in subsequent validation experiments. One potentially
important neuronal AP-1 target discovered, CG6044, was previously implicated in olfactory
associative memory. In addition, 5 mRNAs regulated by RU486, a steroid used to trigger
conditional gene expression were identified.
Conclusion: This study demonstrates a novel role for JNK signaling at the larval neuromuscular
junction and provides a quantitative profile of gene transcription in Drosophila neurons. While
identifying potential JNK/AP-1 targets it reveals the limitations of genome-wide analyses using
complex tissues like the whole brain.
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Background
Conserved neuronal signaling pathways regulate synaptic
plasticity, the ability of neurons to modify synaptic con-
nections. "Long-term" forms of neuronal plasticity require
new gene expression that results in persistent synaptic
change (altered synaptic strength and morphology). Thus,
long-term forms of plasticity may be perturbed, in a vari-
ety of model systems, by protein synthesis inhibitors, or
manipulation of either specific signaling kinases or critical
downstream transcription factors [1-4].
A major requirement in long-term plasticity for the ERK/
MAPK (extracellular signal-regulated kinase subfamily of
mitogen-activated protein kinases) signaling cascade act-
ing through CREB (the cAMP response element binding
protein, a basic leucine zipper – bZIP – transcription fac-
tor) has been supported in diverse experimental para-
digms [1,4,5]. Activation of CREB has been reported to
enhance long-term memory in Drosophila  and rodents,
and long-term facilitation in the sea slug Aplysia [6-11].
Normal ERK signaling is required for hippocampal LTP
formation, for BDNF-induced forms of structural plastic-
ity, as well as for several forms of learning and long-term
memory [12-15]. For example, ERK activation is necessary
for the formation of conditioned taste aversion and spa-
tial learning in rodents, and blockade of ERK signaling
affects long-term, but not short-term, fear conditioning
[16-18]. In addition, ERK regulates synapse plasticity in
flies and LTF and memory in Aplysia [19-21].
Many "immediate-early genes" (IEGs), including mem-
bers of the AP-1 family of transcription factors (het-
erodimeric transcription factor complexes consisting of
the bZIP proteins Fos and Jun), are induced in response to
diverse stimuli in the brain, such as electrical stimulation,
stress, psychotropic drugs, novel experience and spatial
learning [22,23]. Induction of AP-1 mRNA in neurons
requires CREB activation [24]. Although roles have been
established for AP-1 components ∆ FosB and c-fos in syn-
aptic and behavioral plasticity [25-28], the specific mech-
anisms and signal transduction pathways that initiate and
sustain AP-1 dependent neuronal processes have yet to be
elaborated [29]. For instance, the requirement for kinase-
mediated modification of immediate-early transcription
factors remains poorly studied in the context of neural
plasticity, and early-response genes downstream of these
critical IEGs, have not yet been identified.
While the majority of plasticity studies have focused on
CREB and the ERK signaling cascade [5,30,31], recent
studies, especially of other MAP-kinase family members
[32], lead to a broader view of the molecules involved in
neuronal plasticity and memory formation. The JNK/
MAPK (Jun N-Terminal kinase) signaling cascade and AP-
1 proteins have recently been shown to play critical roles
in long-term plasticity and memory formation in mam-
mals [22,26-28,33]. Similarly, p38/MAPK mediates mem-
ory formation in the rat hippocampus [34] and both
short- and long-term synaptic depression in Aplysia [32].
As suggested by its importance in the control of processes
underlying cocaine addiction [29], new data indicate that
AP-1 may widely influence transcriptional events that
underlie long-term synaptic plasticity. AP-1, under regula-
tion by JNK, positively regulates both synaptic growth and
synaptic strength at the Drosophila neuromuscular junc-
tion (NMJ) [35]. At this synapse AP-1 shows a wider range
of influence than CREB whose effects at the same synapse
are limited to controlling synaptic strength [36]. Thus,
while neural induction of Fos and Jun together is suffi-
cient to cause increases in synaptic size and efficacy at the
NMJ, CREB activation, apparently dispensable for synap-
tic growth, is only essential for AP-1 induced changes in
synaptic strength [35-37]. In other neural contexts, the
exact roles and mechanisms of AP-1 and JNK signaling in
long-lasting forms of plasticity are largely unknown [26-
28,33,35,38]. While many genes regulated during CREB
and ∆ FosB (a splice variant of the FosB gene) mediated
cocaine reward [39] have been recently identified, this
study identified exclusively late-response genes whose
expression levels were altered following 5-days to 8-weeks
of either ∆ FosB and CREB overexpression in the nucleus
accumbens, or cocaine injection.
Here, we address two outstanding questions regarding
JNK and AP-1 function in synaptic change. First, using
temporally controlled induction of a JNK-activating
kinase in the fly nervous system, we address synaptic con-
sequences of JNK activation at the Drosophila neuromus-
cular junction. Second, using DNA microarray or SAGE
(serial analysis of gene expression) to profile neuronal
transcripts in control and experimental animals, we iden-
tify groups of neuronal genes potentially regulated by
either: a) JNK, or b) AP-1 in the fly CNS within 6 hours of
pathway activation. Some of these changes were con-
firmed by quantitative real-time RT-PCR (Q-PCR), includ-
ing CG6044, that was previously identified in a screen as
a potential gene required for normal memory formation
in Drosophila [40]. We found five genes are responsive to
the progesterone-related steroid RU486 commonly used
for temporal control of GAL4-restricted transgene expres-
sion in Drosophila  [35,41]. In addition, the mini-white
gene, a common marker used in most Drosophila trans-
genes, is induced strongly by AP-1 and JNK signaling.
These observations and their wider implications are dis-
cussed below.BMC Neuroscience 2005, 6:39 http://www.biomedcentral.com/1471-2202/6/39
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Results
Neuronal JNK activation triggers synaptic growth
To assess the effect of neuronal JNK activation on synaptic
change we expressed an activated JNK-kinase – hemipter-
ous (hepact) [42] – in the nervous system and analyzed
associated phenotypic consequences. Chronic overexpres-
sion of hepact with neuronal GAL4 drivers (C155, C380,
D42 and OK6) caused lethality ranging from late embry-
onic to early 2nd instar larval stages.
In order to overcome this deleterious effect, we drove
expression using the inducible GeneSwitch GAL4 (GS-
GAL4) system to express hepact acutely in postembryonic
neurons [35,41]. Age-selected larvae were exposed to the
inducing ligand RU486 between late 1st instar and early
2nd instar larval stages and allowed to develop to climbing
3rd  instar larval stage. Neural overexpression of hepact
resulted in a 30% increase in bouton number at the larval
NMJ compared to the non-RU486 fed sibling controls
(Figure 1). Changes in synapse size may not be attributed
to the effect of RU486 since wild-type animals fed the ster-
oid did not show a significant change in bouton number
(Figure 1C). Thus, postembryonic activation of JNK sign-
aling in the CNS leads to synaptic growth at the larval
motor synapse.
JNK activation disrupts transmitter release and alters 
presynaptic composition
To evaluate the effect of JNK activation on transmitter
release and postsynaptic response, we measured both
spontaneous and evoked junctional potentials with and
without JNK activation in postembryonic CNS. Increased
hepact  resulted in an unexpected 60% decrease in the
amplitude of excitatory junctional potentials (EJP) (Figure
Postembryonic expression of hepact in larval neurons increases synaptic growth Figure 1
Postembryonic expression of hepact in larval neurons increases synaptic growth. Confocal projections of synaptic 
arbors show that synapse size is increased after hepact induction in postembryonic neurons (B) compared to control (A). C) A 
histogram representation of bouton number shows that hepact overexpression leads to a 31% increase in synapse size (P < 
0.001), while exposing wild-type larvae to the inducible ligand does not cause a significant change in synapse size.
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hepact expression leads to decreased transmitter release Figure 2
hepact expression leads to decreased transmitter release. A) EJP traces from larvae in which hepact expression is 
induced (lower trace) or control (upper trace). Expression of hepact in postembryonic neurons leads to decreases in EJP and 
miniature (m)EJP amplitude by nearly 50% (P < 0.01 for both) compared to control (B, C). D) Quantal content of presynaptic 
transmitter release is reduced by 35% after hepact induction in postembryonic neurons (P < 0.04).
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2A, B). Increased neuronal JNK signaling also decreased
the amplitude of spontaneous responses by ~50% (Figure
2C). The quantal content of presynaptic transmitter
release shows a 30% decrease when hepact is overexpressed
in postembryonic neurons (Figure 2D). Therefore, while
sustained postembryonic JNK activation in the CNS trig-
gers synaptic growth, the strength of the synapse is
reduced. A potential cellular mechanism that underlies
this reduction in quantal content was suggested by immu-
nohistochemical analyses of NMJs in JNK-activated
animals.
Presynaptic proteins including synaptic vesicle proteins,
Synaptotagmin, Csp and antigen(s) recognized by anti-
HRP were substantially decreased when JNK was activated
in motor neurons (Figure 3A–F). Levels of Syt staining
were reduced by 45%, Csp by 30% and anti-HRP by 50%
(Figure 3G). In contrast, postsynaptically enriched pro-
teins, Fasciclin II and Dlg, do not show any change in
intensity.
Because JNK has been implicated in axonal transport, we
asked whether transport defects could possibly explain
how JNK alters presynaptic composition [43,44]. Defects
in axonal cytoskeletal assembly or anterograde axonal
transport cause accumulation of Syt positive puncta on
axonal tracts [44]. Such organelle jams were not present in
axonal tracts of larvae overexpressing hepact. The nerves
were indistinguishable from control animals, indicating
that visible axonal transport defects are not present after
overexpression of hepact (data not shown). For the pur-
poses of this study, these results simply point to potential
effects of JNK activation in the CNS that go beyond its pre-
viously defined role as a positive regulator of AP-1 and,
thereby, of synaptic growth and synaptic strength [35].
Genome-wide screen to identify JNK targets in neurons
To identify transcriptional targets of JNK signaling in the
nervous system we performed a genome-wide analysis of
JNK-responsive genes in the Drosophila larval CNS using
Serial Analysis of Gene Expression (SAGE). SAGE is an
approach that has been extensively used in analyzing
expression changes in cancer cells and other disease states
as well as to analyze gene expression in the Drosophila
embryo and developing eye [45-47]. SAGE is based on
generating unique 14 bp tags at a defined position in
almost every transcript and, following random sequenc-
ing of some 20,000 cDNAs, analyzing the frequency at
which each tag (and hence each transcript) occurs in a
sample RNA. We used SAGE to a) profile gene expression
in the fly central nervous system; and b) identify transcrip-
tional targets of neuronal JNK signaling. To identify early
Presynaptic protein levels decrease with hepact overexpression Figure 3
Presynaptic protein levels decrease with hepact overexpression. Confocal projections of synapses show that levels of 
presynaptic protein synaptotagmin (Syt) (B) and an antigen recognized by anti-HRP (D) are reduced after hepact induction com-
pared to controls (A, C), whereas levels of the postsynaptically enriched protein dlg is similar to control (E) after hepact induc-
tion (F). G) Quantification of fluorescent intensities show that levels of presynaptic proteins Syt, Csp and anti-HRP, are 
reduced by 45%, 34% and 50% respectively (P < 0.001 for all) compared to control. Levels of postsynaptically enriched proteins 
FasII and Dlg go not significantly change after hepact induction in postembryonic neurons.BMC Neuroscience 2005, 6:39 http://www.biomedcentral.com/1471-2202/6/39
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Acute induction of hepact in larval neurons Figure 4
Acute induction of hepact in larval neurons. A) RNA in situ hybridization using a probe specific for hep shows inducible 
expression of hep mRNA in third instar larval CNS. B) Western blot analysis of larval CNS protein extracts shows increased 
levels of activated JNK (P-JNK) after hepact induction. C) A lacZ enhancer trap line of puc shows increased lacZ expression after 
hepact induction in larval CNS. D) A distribution of up- and down- regulated SAGE tags comparing hepact induced and control 
libraries, indicates most tags are present in similar numbers in both the induced and control libraries. E) Functional classifica-
tion of SAGE tags upregulated after hepact induction. Approximately 50% of tags map to genes with no known function and to 
regions of the genome without an identified gene.BMC Neuroscience 2005, 6:39 http://www.biomedcentral.com/1471-2202/6/39
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mediators of synaptic change, we analyzed RNA expres-
sion 6 hours after JNK activation. We induced a 6-hour
burst of neural hepact expression in third-instar larval nerv-
ous systems using RU486 feeding to induce transcription
mediated by neural GS-GAL4. In experimental ElavGS-
GAL4-hepact animals, we confirmed that JNK signaling was
significantly activated by performing the following tests.
Quantitative PCR demonstrated a 16-fold induction of
hep mRNA in larval CNS after hepact overexpression (P <
0.001) (Figure 5). RNA in situ hybridization of RU486
exposed larval CNS showed a marked increase in hep
mRNA localization in the entire larval CNS (Figure 4A).
Immunostaining with an antibody specific for phsophor-
ylated JNK showed induction of hepact mRNA leads to acti-
vation of JNK (Figure 4B). Finally, we observed that
downstream gene expression of a JNK target gene puc
occurs after hepact induction in the CNS. puc  mRNA is
induced nearly 3-fold (P < 0.01) by Q-PCR analysis (Fig-
ure 5) and in an "enhancer trap" lacZ line we were able to
visualize puc promoter activity in the larval CNS (Figure
4C). Thus, our protocol to stimulate neural JNK is suffi-
cient to induce an established downstream target of JNK
signaling. Exposure of identically cultured, wild-type ani-
mals to RU486 did not lead to induction of hep or puc
mRNA or lead to activation of JNK (data not shown).
Hence, changes observed between RU486 treated and
untreated animals should be largely attributable to JNK
signaling in the larval CNS.
We sequenced approximately 20,000 tags from individual
libraries prepared from dissected larval nervous systems of
either control or hepact expressing animals. About 9900
unique SAGE tags represented in these libraries were asso-
ciated with specific genes/genomic sequences using either
a database containing predicted tags of all genes anno-
tated by the BDGP [48] or BLAST searches to identify
other transcription units [45,47]. Approximately 10% of
tags with less than 3 matches to the genome mapped to
regions with no predicted gene. About 12.5% of all tags
did not match the genome probably due to polymor-
phisms, errors in sequencing or possible gaps in the pub-
lished Drosophila genome sequence. Comparison of the
top 60 expressed genes in the CNS SAGE library to embry-
onic and photoreceptor SAGE libraries revealed that while
32% of these genes are highly expressed in all 3 tissues
such as the cytoskeletal protein betaTub56D, 37% are
enriched in the nervous system like the translation elon-
gation factor Ef1alpha100E (see Figure 6). Such compari-
sons could prove useful for understanding transcriptional
regulation and other processes in different tissues (see
Discussion).
Potential JNK-target genes were identified by comparing
the relative representation of specific tags in control and
hepact expressing nervous systems (Figure 4D). A tag was
considered up or downregulated when present 3 or more
times in a given library and changed at least 3-fold
between the two libraries. By these criteria, 346 tags were
increased while 271 were decreased following JNK induc-
tion. Of these, 25 were "upregulated" and 32 "downregu-
lated" more than 8-fold. Approximately 50% of the
induced or repressed tags in the hepact library mapped to
genes that fell into different functional classes, ~35% of
these tags mapped to genes that have no predicted func-
tion and ~10% mapped to parts of the genome without
any predicted genes (see Figure 4E, F).
To determine whether predictions of SAGE could be con-
firmed by more careful single gene analyses, we per-
formed Q-PCR to measure relative levels of expression of
selected candidate JNK-target genes in control and JNK-
induced nervous systems. We selected 61 candidate genes
Q-PCR validation of SAGE results Figure 5
Q-PCR validation of SAGE results. Quantitative com-
parisons of transcript levels in larval CNS RNA from RU486 
treated (hepact induced) versus control samples. Values rep-
resent average cycle difference in PCR product between 
induced and control samples (N = 5). Each cycle change cor-
responds to a 2-fold difference in mRNA levels (see Meth-
ods). After induction of hepact, hep RNA levels increase 16-
fold relative to control (P < 0.001); puc RNA, not identified 
by SAGE, is induced three-fold relative to control (P < 0.01). 
While SAGE targets appl and cher show induction above con-
trol RNA levels, white is induced more than 32-fold (P < 
0.001).
0
1
2
3
4
5
6
hep
puc
appl
cher
0,3 0,0 0,3 1,5
white
0,3 No. of tags
-RU,+RU
C
y
c
l
e
d
i
f
f
e
r
e
n
c
e
f
o
r
c
o
n
t
r
o
l
l
e
v
e
l
o
f
P
C
R
p
r
o
d
u
c
tBMC Neuroscience 2005, 6:39 http://www.biomedcentral.com/1471-2202/6/39
Page 8 of 19
(page number not for citation purposes)
Comparison of the top 60 expressed genes in larval CNS with expression profiles from embryo and photoreceptor cells iden- tified by SAGE Figure 6
Comparison of the top 60 expressed genes in larval CNS with expression profiles from embryo and photore-
ceptor cells identified by SAGE. The top 60 highly expressed tags from the hepact CNS control library were compared 
with control libraries from embryonic [45] and photoreceptor tissues (Jasper and Bohmann, unpublished data). The number of 
tags for each gene is indicated on the left for all three tissues and all libraries examined, normalized, to the same number – 
20,000 – of total tags sequenced. Tag rankings are sorted in descending order for the control library for each tissue using hepact 
CNS control library as reference, after eliminating tags with more than 3 matches to the genome and excluding any ribosomal 
RNA binding proteins (highly enriched) and selecting only tags that mapped to an identified gene. 19/60 (green) highly 
expressed genes in the CNS libraries were also in the top 60 of highly expressed genes in the embryo and photoreceptor 
libraries while 22/60 (white) are found in the top 60 only in the CNS libraries. There were 13/60 (pink) genes found only in the 
top 60 of CNS and photoreceptor libraries and 6/60 (gray) genes found only in the top 60 of CNS and embryo libraries.BMC Neuroscience 2005, 6:39 http://www.biomedcentral.com/1471-2202/6/39
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for such Q-PCR verification based on: 1) an abundance of
tags for that gene in the hepact induced library (9 genes); 2)
an interesting known function for the gene (12 genes); 3)
presence of AP-1 binding sites in the promoter region of
the gene (11 genes); and 4) random selection of genes
that did not fall into the above criteria (29 genes). From
the 61 genes so examined, 15 that showed induction in at
least two independent RT-PCR analyses were analyzed
further, namely more extensive Q-PCR analyses using
RNAs from 5 independent JNK-induction experiments. In
the end, only three genes showed consistent JNK-respon-
siveness (P < 0.05) (Figure 5). white showed consistent
and robust increases in mRNA levels, whereas appl and
cher  showed smaller magnitude inductions. To test if
some of the candidate JNK target genes were robustly reg-
ulated in subsets of neurons, but diluted out in the Q-PCR
analysis, we examined the expression of RNA in the larval
CNS using in situ hybridizations with probes for several
candidate mRNAs. We did not see a clear increase in
expression in any of the putative target genes in hepact
expressing larval CNSs other than white (Figure 10; also
see microarray screen validation).
The small number of SAGE-predicted JNK target genes
confirmed by RNA in situ and Q-PCR analyses was diffi-
cult to explain without multiple repetitions for which
SAGE, being expensive and time-consuming, is not ideally
suited. Also, we speculated that genes expressed at lower
levels than those identified by SAGE may be true JNK/AP-
1 target genes. To test and further these considerations, we
used a different genomic approach – oligonucleotide
microarrays – to search for neuronal AP-1 target genes.
Whole-genome microarray screen to identify direct AP-1 
target genes in the nervous system
We performed comprehensive analyses of transcript levels
in fly heads using Affymetrix Drosophila Genome1 Gene-
Chip arrays representing the entire annotated genome at
the time of its release (~13600 unique genes). An outline
of the microarray screen design is illustrated in Figure 7.
The analysis compared mRNA levels, with or without AP-
1 induction using the same conditional GS-GAL4 strategy
described for the previous SAGE analysis. After treatment
with RU486 for 6 hours to induce fos and jun we consist-
ently achieved, respectively, ~2.5- and 9-fold induction of
fos and jun transcripts in fly heads (quantified by Q-PCR
in 1–3 day old adult flies, Figure 8A). Untreated control
animals showed no significant difference of either gene
when levels were compared between age-matched siblings
from the same experiment (average untreated change).
Each array "experiment" included sibling flies split into
three groups: group A was the experimental (AP-1
induced) population (and groups B and C were independ-
ent controls). Thus, each experiment typically allowed
transcript levels (normalized hybridization signals) to be
compared between experimental and control samples
("A/B" or "A/C" comparisons), and between two identi-
cally treated controls (a "B/C" comparison). Candidate
AP-1 responsive transcripts would be identified as those
with "A/B" and "A/C" ratios significantly different from
control "B/C" ratios. This experimental design was useful
because hybridization signals for some mRNAs varied sig-
nificantly more than others and could potentially con-
found a more straightforward analysis. Through 5–7
repetitions of this basic experiment, we obtained 12 inde-
pendent experimental versus control ratios, and 5 control-
control ratios from which means, variances and SEMs
could be determined. Sibling, age-matched controls used
in each experiment ensured that genetic background,
Microarray experimental design, analysis and validation Figure 7
Microarray experimental design, analysis and valida-
tion. To induce AP-1 in the nervous system, 1–3 day old 
adult ElavGS-GAL4-AP1 flies were treated with the synthetic 
steroid hormone RU486 in 2% sucrose or sucrose alone for 
six hrs. Biotinylated RNA from heads was created and 
hybridized to Affymetrix Drosophila Genome1 GeneChip 
arrays. Gene expression changes between AP-1 induced and 
control samples were considered significant if they passed a 
statistical (P < 0.01, Student's t-test) and secondary filters 
looking at variance in untreated control samples from the 
same experiment. Validation of candidate gene expression 
changes was carried out using quantitative real-time RT-PCR 
and in situ hybridization experiments.
Labeled RNA from heads hybridized to Affymetrix Drosophila GeneChipTM oligo arrays
Observing gene expression changes in ElavGS-GAL4-AP1 flies
AP-1 induced Control 1 Control 2
A B C
Analysis: Average ratio of A/B and A/C compared to expected ratio of 1.0
- Statistical filters based on replicate untreated control samples (Figure 9)
A B C
Validation: Quantitative real time RT-PCR and in situ hybridization
Treatment:
Hybridization:BMC Neuroscience 2005, 6:39 http://www.biomedcentral.com/1471-2202/6/39
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which can have a large effect on transcriptional variance
[49], was not a confounding factor in our analyses.
Based on analyses of 19 hybridizations we established
that basic elements of the array technology, probe labe-
ling, hybridization and scanning, were working efficiently
and reproducibly (See Methods for a complete descrip-
tion). Microarray hybridization data were passed through
three statistical filters to select the most promising AP-1
responsive genes (Methods). Filter 1: We asked that the
average ratio of hybridization signal from AP-1 induced
versus control mRNA hybridization was significantly (P <
0.01) different from 1.0 by Student's t-test. Filter 2: We
asked that the signal ratio be greater than 1.2. Filter 3:
Through analysis of variation observed in identical
control-control comparisons, we ensured that genes
Q-PCR validation of AP-1 induction and microarray results Figure 8
Q-PCR validation of AP-1 induction and microarray results. A) Quantitative comparisons of transcript levels in adult 
head RNA from RU486 treated (AP-1 induced) versus control (black) and control-control (gray) samples. Values represent 
average cycle difference in PCR product between samples being compared (N = 5). Positive values indicate an increase in tran-
script compared to unchanging reference gene, negative values a decrease. fos, jun, white and CG6044 RNA levels are increased 
in the fly head after AP-1 induction in the nervous system while untreated control levels show no significant difference. B) 
Comparisons of transcript levels in adult head RNA from RU486 treated versus control samples. CG2016, CG11191 and 
CG15438 levels are induced in all samples from flies fed the steroid hormone RU486 (N = 3). X-axis in panel B indicates the 
UAS-transgene(s) induced by ElavGS-GAL4 (AP1: UAS-fos;UAS-jun). *Average difference between samples significant at P < 0.05 
(Student's t-test).
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passing filters 1 and 2 did not show wide variability, for
instance based on physiological states of the flies.
Using filter 1: of the ~5200 genes considered for analysis
(those with relatively strong and specific hybridization
signals), 269 showed altered expression after AP-1 induc-
tion, with a significance of P  < 0.01 (Student's t-test).
Strikingly, 167 genes showed significant upregulation
while only 102 were downregulated, a skew consistent
with AP-1's expected role as a transcriptional activator.
269 candidates, at P < 0.01, is substantially larger than
predicted by random chance (52 genes – 0.01 × 5200
genes). However, when a second filter – a requirement
that the signal ratio modulus be greater than 1.2 – was
applied, the number of candidates dropped to 115.
Though small, such signal ratios could correspond to
higher mRNA ratios and have been reported as meaning-
ful in previous microarray experiments. Filter 3, to elimi-
nate "variable" genes, trimmed the list of candidate genes
that respond consistently to AP-1 overexpression in the fly
head to either 4 (P < 0.01) or 16 (P < 0.05, listed in Figure
9) for which "A/B" and "A/C" ratios were significantly
greater than control "B/C" values by Student's t-test.
An internal control for the array screen and analysis was
provided by Drosophila Jun (Jra), whose mRNA was exper-
imentally induced. We found that jun ranked highest once
all three filters were applied and showed robust induction
with an average log2 treated expression ratio of 1.26 (P =
5.9e-11) and an average untreated expression change of
only -0.07 (Figure 8A). In contrast, fos did not pass these
stringent filters although we consistently observed an
average 2.3-fold increase in fos transcript levels by quanti-
tative RT-PCR (Figure 8A). This discrepancy may arise
from either of two limitations: a) that fos is a low-abun-
dance transcript in the fly head, below the threshold for
quantifiable gene expression change detection using
Affymetrix GeneChip arrays; or b) the fos probe on this
particular array may not perform reliably [50], perhaps
hybridizing to other non-specific RNA probes. Many gene
probes could have similar problems; indeed, other
Top 15 candidate AP-1 responsive genes identified by microarray analysis Figure 9
Top 15 candidate AP-1 responsive genes identified by microarray analysis. Genes altered following neuronal AP-1 
overexpression, passing statistical (Student's t-test, P < 0.01) and secondary filters based on ratio thresholds and variance in 
untreated control samples from the same experiment. Arrows on left indicate directionality of expression change listed in 
order of magnitude from largest positive ratio (induction) on top to largest negative ratio (repression) on bottom. jun induc-
tion shows the largest expression change by these criteria. Predicted functions from Flybase [70]. Bold type highlights expres-
sion changes confirmed by Q-PCR (n.t. = not tested). Blue type highlights RU486-responsive genes. *VGA – volatile general 
anesthetic.
Cyp4e3
CG3348
Rtnl1 (CG18623)
Lsd-1 (CG10374)
CG5853
BcDNA:GH07485 (CG5009)
ATPCL
Msp-300
BcDNA:GM04682 (CG2358)
vermilion
CG6044
nop5
CG11796
white
CG11191
Jun (Jra)
Neuronal Phenotype Molecular Function Confirmed? Gene Name P
Putative memory gene
Courtship, VGA* resistance
NMJ plasticity
cytochrome P45
chitin-binding domain
receptor signaling protein
lipid storage
ATP-binding cassette transporter
palmitoyl-CoA oxidase
ATP citrate lyase
muscle-specifiic protein, cytoskeletal protein binding
signal peptidase
tryptophan 2,3-dioxygenase
unknown
RNA-binding
4-hydroxyphenylpyruvate dioxygenase
ATP-binding cassette transporter, ommochrome biosynthesis
unknown
Jun-related antigen, RNA Polymerase II transcription factor
n.t.
yes
no
no
yes
no
no
n.t.
no
no
yes
n.t.
no
yes
yes
yes 5.9e-11
2.2e-7
2.0e-5
3.3e-5
.002
.0002
.001
.0001
.001
.0006
.007
.0007
.0004
.0009
.0005
.001BMC Neuroscience 2005, 6:39 http://www.biomedcentral.com/1471-2202/6/39
Page 12 of 19
(page number not for citation purposes)
transcripts may exhibit altered expression levels beyond
the scope and sensitivity of this assay.
We searched promoters (sequences 3 kb upstream of the
translation start sites) of the top 15 candidate AP-1
responsive genes for conserved AP-1 or CREB binding
sites and compared their frequencies of occurrence in this
group with frequencies observed in a control group of 15
genes that appeared insensitive to AP-1 induction. This
analysis revealed no significant enrichment of CREB or
white transcript levels are induced when positive JNK pathway components are overexpressed in the fly nervous system Figure 10
white transcript levels are induced when positive JNK pathway components are overexpressed in the fly nerv-
ous system. A) Quantitative comparisons of white transcript levels in adult head RNA from RU486 treated versus control 
samples. PCR primers designed to the 3' end of white (black), but not 5' primers (gray), show increased levels in response to 
AP-1 and hepact induction (N = 3). Wild-type flies exposed to hormone or flies overexpressing fbz do not show induction of 
white. X-axis indicates the UAS-transgene(s) induced. *Average treated difference significant at P < 0.05 (Student's t-test). B)in 
situ confirmation of increase in white transcript levels following hepact induction in the larval CNS.
AP1
hep act
hep act ;
AP1 fbz
wild type
*
-1
0
1
2
3
4
*
*
C
y
c
l
e
d
i
f
f
e
r
e
n
c
e
f
o
r
c
o
n
t
r
o
l
l
e
v
e
l
o
f
P
C
R
p
r
o
d
u
c
t
Genotype:
w – 5’ primers
w – 3’ primers
AB
induced
control
hepact/+;elavGSG/+BMC Neuroscience 2005, 6:39 http://www.biomedcentral.com/1471-2202/6/39
Page 13 of 19
(page number not for citation purposes)
AP-1 binding elements in promoters selected based on the
microarray experiments (data not shown).
Microarray screen validation
A major task after initial microarray screening has been
completed is confirmation of candidate gene transcript
level changes using secondary, independent tests for gene
expression. Although the frequency of false-positives is
substantially reduced through repetition, a subset of
observed expression differences should be validated by
other methods.
To confirm positives, a subset of the most robustly chang-
ing AP-1-responsive genes, exhibiting significant up- or
down-regulation by microarray analysis, were selected as
candidates for real-time quantitative RT-PCR validation
using gene specific primers (see Figure 9). 12 genes chosen
from the group of 15 top candidates mentioned above, in
addition to more than 30 genes from outside this
stringent set – those with very low "P" values or specific
predicted biological functions – were selected for these
more careful confirmatory experiments. Increases in tran-
script levels following AP-1 overexpression, detected by
Q-PCR, for fos, jun and 2 confirmed candidate genes
(white and CG6044) are shown in Figure 8A. All mRNA
levels are normalized to the control gene rp49. Transcript
levels for a second control gene, gapdh1, are shown to
demonstrate its levels do not change significantly by
either AP-1 induced versus control ("A/B", "A/C") or con-
trol-control ("B/C") comparisons.
Five uncharacterized genes (CG2016,  CG11191,
CG15438, CG5853 and CG3348) were confirmed by Q-
PCR to be consistently altered in RU486-treated, AP-1
induced samples (Figure 9, Figure 8B – data for CG5853
and CG3348 not shown). In addition, overexpression of
fbz with RU486 treatment also caused a similar change in
transcript levels of these 5 genes. When treated with the
steroid, wild type flies and all other transgenic lines tested
showed consistent alterations of these 4 mRNA transcripts
in the head, suggesting they are hormone-responsive
genes in the fly.
As in the larval CNS, Q-PCR experiments confirmed white
gene induction in the adult fly head. white transcript levels
are significantly increased in the head following AP-1
overexpression in the brain (Figure 8A, Figure 9, Figure
10). Further Q-PCR experiments demonstrated white tran-
scripts are increased to an even greater extent when hepact
is induced in combination with AP-1 or by itself in the
adult nervous system (Figure 10A), although its levels are
not increased to the degree seen in the larval CNS (Figure
5). white is not induced when fbz is overexpressed, nor in
wild type flies treated with RU486. Only primers designed
to the 3' portion of the white transcript showed altered lev-
els (Figure 10A), which is consistent with the background
strain used in all the experiments(w1118). This strain lacks
the 5' portion of the white gene locus [51], yet still con-
tains sequence for and expresses the second through fifth
exons (data not shown) that are induced in response to
JNK signaling in the fly head. The same transcriptional
induction profile is observed in ElavGS-GAL4-hepact flies
with the wild-type (w+) copy of the white gene on the X
chromosome as well as in a white  null (w11E4  [52])
background (data not shown). This suggests white induc-
tion occurs via the mini-white cassette present in pUAST
transgenes. RNA in situ hybridization experiments con-
firmed the increase in mini-white transcript levels in the
CNS of larvae in which hepact has been induced (Figure
10B). Increases were also observed in larvae overexpress-
ing AP-1 (data not shown), albeit with smaller magnitude
changes consistent with our findings from Q-PCR analy-
ses in the adult head (see Figure 10A).
CG6044  induction following AP-1 overexpression was
also confirmed in independent Q-PCR experiments
(Figure 8A). Consistent increases in transcript levels were
observed in all AP-1 overexpressing heads but not in
treated  fbz  or wild type heads (data not shown). The
induction observed by quantitative RT-PCR and microar-
ray experiments was not reflected in follow-up in situ
experiments; however, this is likely because the small
magnitude increases in transcript levels observed by other
means (1.2-fold – microarray; 1.4-fold – Q-PCR) are
below the detection range for this method.
Discussion
This extensive study makes three contributions: (A) it
demonstrates unexpected and novel interactions between
JNK and cellular processes that underlie synapse plasticity;
(B) by SAGE analyses, it provides a genomic profile of
mRNAs expressed in the fly larval nervous system; (C) it
presents two large-scale genomic approaches to identify
JNK and AP-1 targets in the fly CNS providing useful data
pertinent to JNK/AP-1 signaling in neurons as well as to
genomic analyses in the Drosophila nervous system.
Effects of JNK activation in postembryonic motorneruons
The immediate-early transcription factor AP-1 positively
regulates both synapse size and synapse strength at the
Drosophila larval NMJ [35]. While JNK signaling is neces-
sary for the effect of AP-1 on synapse structure and func-
tion, it is not clear whether JNK signaling is sufficient for
synaptic change. We show, first, that activation of JNK in
post-embryonic neurons leads to significant synaptic
alterations; second, that these alterations are inconsistent
with JNK functioning solely through AP-1. Our finding
that activation of JNK signaling leads to an increase in syn-
apse number but decreases synapse strength indicates that
JNK activates not only AP-1, a positive regulator of growthBMC Neuroscience 2005, 6:39 http://www.biomedcentral.com/1471-2202/6/39
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and strength, but also a pathway that negatively influ-
ences synaptic strength.
The neural transcriptome, and its regulation by JNK and 
AP-1
The ability of SAGE to evaluate absolute expression levels
of gene transcripts enables relatively facile, quantitative,
profiling of gene expression in any given tissue (or RNA
source). Given the intense interest in Drosophila neurobi-
ology, a previous painstaking sequence analysis of some
1000 cDNAs from a fly brain cDNA library provided use-
ful new information on the neural transcriptome [53].
The analysis presented here, following sequencing of
about 20,000 ESTs from two independent brain libraries,
substantially extends the previous study. The use of this
resource is demonstrated by our simple survey of highly
expressed neuronal RNA-binding proteins, potentially
involved in important neural-specific, post-transcrip-
tional functions such as translational repression, mRNA
transport or RNA editing. 10% of the 60 most highly
expressed (non-ribosomal) mRNAs in nervous system
encode RNA-binding proteins, 2 of which are enriched in
neurons versus embryonic tissue. A significant fraction of
these (3/6) have conserved homologs recently found on
RNA granules, organelles containing translationally
repressed mRNAs which are actively transported to
synaptic sites [54]. We have recently begun functional
analyses of some of these RNA-binding proteins.
Similarly, we anticipate that identification of tissue-spe-
cific genes could provide unanticipated launch points for
investigation into their cellular functions.
Given the evidence to indicate wide effects of AP-1 and
JNK on synaptic properties, we searched for AP-1 and
JNK-target genes using both SAGE and microarray
approaches to determine effects of JNK and AP-1 signaling
on neuronal gene expression. Of the two approaches,
microarray analysis, being dependent on parameters such
as hybridization and labeling efficiencies that vary among
individual transcripts, is not ideal for quantitative analy-
ses as outlined in the previous section. However, it pro-
vides information on transcripts with low to moderate
levels of expression, is fast, and allows multiple iterations
of each experiment at a small cost relative to SAGE.
In order to identify early transcriptional targets, most
likely to link JNK and AP-1 activation to synaptic change,
we used the steroid-inducible GAL4 system, an increas-
ingly popular strategy to achieve conditional, tissue-spe-
cific transgene expression in Drosophila  [35,41,55,56].
SAGE-derived transcript profiles of RNA extracted from
whole larval CNSs showed several potentially significant
targets. However, very few were confirmed by secondary
low-throughput, gene-specific analyses. Microarray-
derived transcript profiles of adult head mRNA showed
similar results. Several statistically significant targets of
AP-1 signaling were initially identified; however, few were
confirmed by carefully controlled application of the most
commonly used transcript-specific analyses (quantitative
RT-PCR and in situ RNA hybridizations). While the impli-
cations of these results for neurogenomics are briefly dis-
cussed in the next section, we first consider the "positive"
genes identified by SAGE and microarray screens.
Quantitative RT-PCR validation of the generated SAGE
data resulted in the identification of 3 genes, cher, appl and
white, which were consistently upregulated following JNK
activation in the larval CNS. Though we were unable to
evaluate induction of cher and appl by RNA in situ hybrid-
ization, white showed robust increases by this method as
it did by Q-PCR. A total of seven expression changes iden-
tified in the microarray screen were verified by Q-PCR
analysis; remarkably, five turned out to be genes respond-
ing to RU486 treatment itself rather than to consequent
AP-1 induction. These steroid-responsive genes may be of
significant biological interest. However, from our point of
view they serve primarily to: a) further establish the
bonafides of our experimental and analytical protocols;
and b) as a useful caution for Drosophilists and others
using the steroid-inducible conditional expression sys-
tem. The remaining two confirmed AP-1 target genes were
w hite, also identified in the SAGE screen but shown even-
tually to be expressed from the P-element associated mini-
white  locus, and CG6044. Of potential significance,
CG6044  has been implicated in olfactory associative
memory [40].
AP-1 responsiveness of CG6044 was verified in Q-PCR
validation experiments (Figure 8). The gene was previ-
ously found in a mutational screen for putative memory
genes required for normal olfactory conditioning in Dro-
sophila [40]. In addition, it is one of the few genes from the
list of likely AP-1 targets (listed in Figure 9) that has a con-
served AP-1 binding site within 500 base pairs of its trans-
lation start site. It is therefore a promising candidate
warranting further investigation into the role it plays in
synaptic plasticity and memory formation.
Lessons and limitations
It appears unlikely, if not inconceivable, that the 4 proba-
ble downstream genes enumerated above could mediate
the demonstrated effects of AP-1 or JNK induction on
motor-synapse properties. Thus, the genomic approaches
we have followed, while informative, have likely not led
to the identification of JNK/AP-1 targets that link these
signals to synaptic change. One possible interpretation,
that the experiments were technically flawed, appears to
be ruled out, not only because internal controls (Jun, Hep,
Puckered and steroid-responsive genes) were identified in
the screens, but also because various standards for micro-BMC Neuroscience 2005, 6:39 http://www.biomedcentral.com/1471-2202/6/39
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array hybridization data and SAGE library complexity
were evaluated and shown to be well within the techni-
cally optimal range. Thus, we are left with the second
interpretation, that analysis of whole-brain mRNA may
not allow targets of signaling pathways to be unambigu-
ously identified. A major issue is likely to be cell-type het-
erogeneity within the brain. If different subsets of neurons
show substantially different genomic responses to JNK/
AP-1 (including the absence of a response), then altered
expression of the meaningful JNK/AP-1 targets in a subset
of cells may be diluted by the large background of mRNA
deriving from other neuronal types.
At a conceptual level, Barolo and Posakony have nicely
articulated the concept of "activator insufficiency" and the
need for cooperative activation of multiple transcription
factors for turning on transcriptional pathways governing
developmental processes [57]. Considerable evidence
argues that neurons are a diverse class of cells with a range
of distinct transcriptional ground states. For example, cell-
type-specific binding of CREB to known target gene
promoters has been shown in various cell types under
basal and stimulated conditions [58]. Similarly, the
response of different neuronal populations to TGFβ  has
been shown to be highly context dependent and to derive
from variations in expression of specific TGFβ  insensitive
transcription factors [59]. Thus, genomic analyses when
applied to whole nervous systems may have significant
intrinsic limitations.
Nevertheless, some conserved downstream genes may still
be revealed [60-63]. For instance, the steroid hormone,
RU486, used to induce transgene expression in our exper-
iments presumably activates a set of hormone-responsive
genes in a large subset of neural cells. However, for inci-
sive mechanistic analyses for which Drosophila is so con-
venient, we suggest that genome-wide screens described to
study signaling responses in the nervous system be
applied with specific refinements, such as emerging
methodologies to prepare sufficient mRNA from a homo-
geneous population of cells in which biological function
of these signaling pathways have been evaluated [64]. Var-
ious GFP transgene lines should make it possible to sort
specific cell populations prior to genomic screens to iden-
tify transcriptional targets.
The availability of new genetic and molecular tools and
refined functional genomic approaches should result in
continued understanding of how kinases and transcrip-
tion factors regulate molecular changes that occur in the
Drosophila nervous system, as well as intrinsic flexibility
and constraints of these signaling pathways.
Conclusion
This study revealed unexpected relationships between JNK
signaling and synaptic plasticity in Drosophila  that are
inconsistent with a role for JNK acting solely through AP-
1 to affect strength of the synapse. It also presents a profile
of the transcriptome of the larval nervous system and,
while providing potential transcriptional targets of JNK
and AP-1 signaling in neurons, points out the pitfalls of
genome-wide analyses in complex tissues such as the
whole fly nervous system.
Methods
Fly strains and genetics
We used the following strains: wild type (Oregon R; D.
Brower); GAL4-responsive UAS-hepact (M. Mlodzik), UAS-
fbz, UAS-fos, UAS-jun (M. Bienz), puc-lacZ line – puce69(A.
Martinez Arias); neural GAL4 lines – C155, C380, D42 and
OK6 were from C. Goodman, V. Budnik, G. Boulianne
and B McCabe, respectively; ElavGS-GAL4 line was from T.
Osterwalder and H. Keshishian.
Postembryonic and acute induction in neurons
Induction in larvae
All animals were generated by crossing males
homozygous for UAS-transgenes (or wild-type males)
with virgin females homozygous for the ElavGS-Gal4
driver. All animals were raised at 25°C and parents trans-
ferred to a new vial each day for age-selection of larval
instar stages. For postembryonic induction, larvae in vials
that should contain a majority of late 1st instar-early 2nd
instar were transferred into a standard vial containing
0.015 mg/ml RU486 (Sigma) for 48 hrs before climbing
third instar larvae were selected for further analysis. Con-
trol animals were exposed to food containing only 4%
ethanol (same as treated) and analyzed accordingly. For
acute induction in 3rd instar larvae, age-selected larvae
were transferred to a 1.5 ml sample tube containing 0.5
ml of 3 mg/ml RU486 for 2 min, before they were washed
and transferred into a standard vial containing 0.015 mg/
ml RU486 (Sigma) for 6 hrs before the CNS was dissected
for further analysis.
Induction in adults
As in larvae, all animals were generated by crossing males
homozygous for UAS-transgene constructs (or wild-type
males) with virgin females homozygous for the ElavGS-
GAL4 driver. Progeny reared at 25°C were aged to be 1–3
days old at time of treatment. 16–64 hour old adults were
starved for 8 hours in a Tupperware container filled with
desiccant to keep the humidity level at ~16% and ensure
ingestion of the treatment medium. Flies were then split
into separate bottles and fed for 6 hours. Each treatment
consisted of ElavGS-GAL4-UAS flies handled identically
(aged and starved in the same bottle) except RU486 was
added to the sucrose fed to the experimental group. Exper-BMC Neuroscience 2005, 6:39 http://www.biomedcentral.com/1471-2202/6/39
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imental animals were fed on a kimwipe soaked with
RU486 in 2% sucrose at a final concentration of 0.04 mg/
ml, taped to the bottom of a large, dry, empty bottle. Sib-
ling control flies of the same genotype were fed sucrose
alone.
Immunostaining
Larvae were raised at 25°C after postembryonic induction
of UAS transgenes, dissected, stained with anti-Syt anti-
body and mounted. Bouton number was counted from
projections of confocal sections at 60X magnification.
Boutons at segment A2 in muscle 6 and 7 were manually
counted without knowledge of the genotype (blind count-
ing), using Metamorph imaging software. No significant
difference in muscle surface area, measured using a draw-
ing tool in Metamorph was observed in the different gen-
otypes. To quantify levels of synaptic proteins synapses
labeled with specific antibodies; anti-syt, anti-csp, anti-
HRP, anti-fas II, anti-dlg, were identically imaged for con-
trol and induced animals and the average pixel intensity
of terminal boutons (3–4) was measured and analyzed.
To quantify organelle accumulation on axons after hepact
induction, larval segmental nerves were imaged at high
resolution using a cooled charge-coupled device camera
(Princeton Instruments) and Metamorph imaging soft-
ware (Universal Imaging). After background subtraction,
images were analyzed for organelle jams and compared
with control animals.
Electrophysiology
All electrophysiological recordings were made from mus-
cle 6 within A2, with the larval preparation immersed in a
low volume of the HL3 saline with 1 mM Ca2+. Electro-
physiology was performed as described previously. In all
experiments, the CNS was gently removed to prevent
endogenous motor firing. Motor nerves were stimulated
with glass-tipped suction electrodes. For intracellular
recordings, electrodes pulled from borosilicate capillary
tubes were backfilled with 3 M KCl, yielding resistances of
6–10 MΩ . To ensure good recordings, preparations with
resting potentials more positive than -60 mV were dis-
carded. For recording excitatory junctional potentials
(EJPs), an isolated pulse stimulator (A-M systems, Everett,
WA) was used to deliver 1 msec pulses at a frequency of 1
Hz to elicit an evoked response. All recordings were
acquired with an axoclamp 2B amplifier in conjunction
with pClamp 6 software (Axon Instruments, Foster City,
CA). The EJP amplitude for each preparation was deter-
mined from an average of 15 consecutive evoked
responses. For quantifying mini frequencies, the number
of mEJPs occurring consecutively within 30 sec was
counted for each preparation. The mEJP amplitude for
each preparation was determined from an average of 30
consecutive mEJPs. At least 5 animals were analyzed for
each genotype. For each animal examined that was
exposed to RU486 treated food, we examined control ani-
mals and expressed the quantal content of transmitter
release as a percentage of control.
Serial Analysis of Gene Expression (SAGE)
SAGE was performed as previously described [45,47].
Briefly, polyA mRNA from 50 CNSs dissected out of drug
treated 3rd  instar larvae was purified with dynabeads
mRNA direct kit (Dynal). Double-stranded cDNA was
synthesized on the beads and digested with the anchoring
enzyme (NlaIII; NEB). After linker ligation, digestion with
the tagging enzyme (BsmFI, NEB), and ligation of the dit-
ags, PCR amplification (29 cycles) was carried out with
20% of the ligation product as template. The 100 bp PCR
products were purified and submitted to a secondary PCR
(10–12 cycles) with biotinylated primers to generate
enough material for the concatemerization. After NlaIII
digestion, the released ditags were purified by polyacryla-
mide gel electrophoresis and subsequently incubated with
100  ul of Dynabeads Streptavidin to eliminate any
remaining biotinylated linkers. Concatemerization was
carried out for four hours. Concatemers were cloned into
the SphI site of pZero1 (Invitrogen), and resulting colo-
nies were screened for inserts by PCR and submitted for
sequencing. All sequencing reactions and SAGE tag gener-
ation was performed at Agencourt Inc. (Boston).
Analysis of SAGE Data and Annotation of SAGE Tags
Sequenced SAGE concatemers were analyzed using the
SAGE2000 program obtained from The Johns Hopkins
University (see also [65]). The database linking SAGE tags
to data of the Berkeley Drosophila Genome Project was
built using datasets downloaded from the BDGP site [66]
and extracting the 10 bp sequence downstream of the 3'-
most CATG site. These putative tags were linked to the
GadFly site of the corresponding gene. Annotation of
experimental data was performed using Microsoft Access
to link the experimental dataset and the Tag annotation
database [45,47].
Microarray analysis
Total RNA was extracted from 200–300 heads of RU486-
treated (AP-1 induced) and untreated control ElavGS-
GAL4-AP1  flies (w1118;UAS-fos/+;UAS-jun/ElavGS-GAL4)
using the RNeasy kit (Qiagen). 5 ug of total RNA was used
as a starting template for 19 microarray hybridizations (7
treated and 12 untreated RNA samples). Two sets of con-
trol flies were included for analysis in five of the seven
experimental AP-1 overexpression treatments used for the
microarray hybridizations. Transcript quantification was
performed with Affymetrix Drosophila  Genome1 Gene-
Chip [67] arrays using biotinylated cRNA targets prepared
according to standard Affymetrix protocols by the GATC
Affymetrix Core Facility at the University of Arizona [68].
Hybridized arrays were scanned using Affymetrix Micro-BMC Neuroscience 2005, 6:39 http://www.biomedcentral.com/1471-2202/6/39
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ArraySuite software as described in the manufacturer's
protocol. All hybridizations were normalized with a glo-
bal scaling factor of 500 so that transcript levels could be
compared directly. Text files containing raw, normalized
values were exported into Excel for further analysis.
Internal control, 3'-5' probe signal ratios (a measure of
how well the biochemical reactions went prior to hybrid-
ization of the biotinylated probe to the oligonucleotide
array) were within the range recommended by the manu-
facturer for all hybridizations. R2 values for all compari-
sons of control versus control samples from the same
experimental group were high (≥  0.97).
Between 41% and 49% of all genes were scored present or
marginal on each of the arrays by MicroArraySuite. In
order to avoid spurious data, only the 5188 genes present
or marginal in all 7 AP-1 induced samples were consid-
ered for further analysis (~38% of all probes on the array).
Ratios between AP-1 induced and the 1 or 2 control sam-
ples from a given treatment were calculated in Excel. Fold-
differences were converted to log2 values so that increas-
ing and decreasing levels of mRNA could be compared
directly. Log2 values (n = 12) were tested against the value
of 0, expected if there were no change in expression, using
the Student's t-test (unpaired t-test, two-sided P, samples
with unequal variance estimates). The P-values accepted
for our analysis (P < 0.01) therefore reflect a 99% proba-
bility that the null hypothesis (there is no difference in the
expression of a given transcript in AP-1 induced samples)
should be rejected.
Secondary filters to eliminate false positives and ran-
domly fluctuating transcripts included: 1) the average AP-
1 induced versus control ratio (n = 12) for a given gene
had to be 1.2 or higher; 2) Log2 values for the expression
ratio, comparing AP-1 induced to control signals for a
given gene (n = 12), were tested against the values of con-
trol versus control ratios (n = 5), again using the Student's
t-test – genes passing this statistical filter (P < 0.05) were
considered to be changed beyond the dynamic nature of
the transcript.
Quantitative real time RT-PCR and in situ hybridization
Larval CNS
To quantify RNA expression, approximately, 25 larval
brains were dissected for each sample. PolyA mRNA was
isolated using the Dynabeads mRNA direct kit (Dynal)
and oligo dT-primed cDNA was synthesized with the
Omniscript cDNA synthesis kit (Qiagen). The cDNA was
diluted 1:5 for Q-PCR reactions performed on a Cepheid
SMARTCycler using QuantiTect SYBR Green PCR kit (Qia-
gen). Transcript levels were determined using gene-spe-
cific primer sets (details available on request). Expression
differences are shown as the average change in cycle
number at which PCR product (determined by fluorescent
signal) is detected as statistically significant above back-
ground. This is referred to as the crossing threshold and
the more cDNA template present at the start of the reac-
tion, the fewer number of cycles it takes to reach this
point. A one-cycle difference represents a two-fold differ-
ence in starting template concentration. All transcript lev-
els are normalized to the control gene, ribosomal protein
49 (rp49), as previously described [35].
Adult heads
Independent RNA samples were extracted as for microar-
ray experiments for all Q-PCR comparisons. Equal
amounts of total RNA (4 ug) for RU486-treated (induced)
and untreated control samples were purified from
genomic DNA with the DNA-free DNase kit (Ambion)
prior to oligodT-primed cDNA synthesis using the Omnis-
cript cDNA synthesis kit (Qiagen). The cDNA was diluted
1:20 with nuclease-free H2O (Invitrogen) for Q-PCR reac-
tions performed as described above. Each PCR reaction
was repeated in triplicate for 3–5 independent RNA
preparations from separate RU486 treatments. Sample
sets were compared using the Student's t-test as for the
array analysis and only results showing a P-value <0.05
were considered statistically significant.
In situ hybridizations were performed using probes pre-
pared with PCR DNA (400–600 bp) from primers specific
for gene of interest containing T7 RNA polymerase bind-
ing site in the sense orientation and SP6 RNA polymerase-
binding site in the antisense orientation. RNA probes were
labeled with DIG and visualized using either NBT/BCIP
(blue reaction product). Larval CNSs were dissected after
drug treatment and the tissue was processed using stand-
ard protocols [69].
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